Studies found no heterogeneity of GLP1-RA relative treatment effect by age121, blood pressure122,123, diabetes duration124, history of cardiovascular disease/heart failure122,125 or use of RAS inhibitors122. This evidence concerns the gene GLP1R and diabetes mellitus.